← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
ESAB Corp: Revenue grew 3.7% to $2.843B from $2.741B. Net income declined 14.4% to $227M from $265M. Free cash flow declined 29.8% to $213M from $304M. Operating margin contracted 183 bps to 14.50%. ESAB Corp's annual comparison also shows free cash flow declined despite revenue growth; inventory grew faster than revenue.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 3.7% to $2.843B from $2.741BOK
- Profitability — Net income declined 14.4% to $227M from $265MWatch
- Cash flow — Free cash flow declined 29.8% to $213M from $304MWatch
- Margins — Operating margin contracted 183 bps to 14.50%Watch
- Accounting — No overriding statistical warningNote
- Insiders — 1 purchase and 5 salesOK
Business
Our business operates in highly fragmented and competitive markets.
Where the revenue comes from
Fiscal 2025, as ESAB Corp reports it. History and quarterly detail are in the app.
- EMEA and APAC$1.7B
- Americas$1.1B
Leadership changes
From ESAB Corp's own filings, the day they're filed.
- Mitchell P. Rales · Directors · appointmenteff. 2026-06-10
- Rhonda Jordan · Director · appointmenteff. 2026-06-10
- Julie Han · principal accounting officer · appointmenteff. 2026-04-01
Latest filings
- 8-K · Company announcement2026-08-06
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-06-12
- 8-K · Company announcement2026-06-02
- 8-K · Company announcement2026-05-12
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about ESAB Corp, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.